Solna, Sweden
At Alder Therapeutics, we are on a bold mission to cure the incurable by bringing pluripotent stem cell-developed therapies to the benefit of patients. We are developing two promising allogeneic stem cell therapies, both with pre-clinical proof of concept data. Our lead program is a retinal cell therapy to treat Retinitis Pigmentosa, with a second program to tackle heart failure. Our industry-renowned team has decades of expertise in the scientific, technical and commercial aspects of bringing game-changing allogeneic cell therapies to market. Our focus is on de-risking cell therapy development by keeping the commercial product in mind from the start.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Alder Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
